Newsroom - Page 6

A new study by researchers at the Institute of Cancer Research has substantiated that hormone replacement using estrogen and progesterone increases the risk of breast cancer, especially with longer use.
What we're reading, August 23, 2016: Republicans in Congress indicate they may be willing to fix the Affordable Care Act instead of repeal it once President Obama is out of office; an Alzheimer's drug receives fast-track designation from the FDA; and Pfizer to acquire Medivation.
A new report by the Harvey L. Neiman Health Policy Institute recommends a bundled payment model for breast cancer screening, with the objective of improved patient care and a more efficient use of healthcare resources.
A $245 million priority review voucher is essentially wasted, not over the therapy, but the delivery device.
Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs.
Diabetes advocate Kelly Close of diaTribe and Close Concerns wrote in a blog post that those with diabetes can make a video to share with the FDA.
Factors such as insurance status and being married are significant determinants of survival compared with race/ethnicity, in patients with multiple myeloma who are less than 65 years of age.
What we're reading, August 22, 2016: freestanding emergency clinics come under increased scrutiny; hospitals are being more open about medical mistakes; and regulations to blame for rising generic drug prices.
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium